Who makes Clopirin 1?

Clopirin 1 is developed by Jeil Pharmaceutical Co., Ltd..

What development phase is Clopirin 1 in?

Clopirin 1 is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Clopirin 1

Jeil Pharmaceutical Co., Ltd. · FDA-approved active Small molecule Quality 2/100

Clopirin 1, marketed by Jeil Pharmaceutical Co., Ltd., holds a position in the pharmaceutical market with its key composition patent expiring in 2028. The drug's primary strength lies in its current marketed status, providing a stable revenue stream for the company. The primary risk is the patent expiry in 2028, which could lead to increased competition from generic versions.

At a glance

Generic name	Clopirin 1
Sponsor	Jeil Pharmaceutical Co., Ltd.
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Trial to Assess the Efficacy of Combination Formula of Aspirin Plus Clopidogrel in Patients With Coronary Stent (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results